Skip to content

Insights in proximal and distal tubular iron reabsorption by studies on urinary iron excretion in human health and disease

Insights in proximal and distal tubular iron reabsorption by studies on urinary iron excretion in human health and disease - Renal iron reabsorption in human health and disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43424
Enrollment
60
Registered
2016-06-16
Start date
2016-07-25
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ijzerstapelingsziekten Renal disease systemic iron overload

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers: age 18-80 years of age. Subjects with tubulopathy: age 18 - 80 years, diagnosed with tubulopathy by treating physician (e.g. Fanconi syndrome, Dent's disease, Wilson's disease, cystinosis, tubulo-interstitial nephritis (TIN) or suffers from tubulopathy secondary to e.g. multiple myeloma of secondary nephrogenic diabetes insipidus (sNDI)). This group also comprises subjects with tubulopathy and glomerulopathy: 18-80 years of age, proteinuria (EKR> 0.2 g/ 10 mmol creatinine), tubular dysfunction (urinary excretion of *1-microglobulin (>50 ug/min) and/or *2-microglobulin (>1 ug/min). Subjects with systemic iron overload: age 18-80 years of age, diagnosed with HFE-hereditary hemochromatosis, b-thalassemia major or intermedia, or Diamond Blackfan anemia by treating physician, with transferrin saturation (TSAT) > 70%.

Exclusion criteria

Exclusion criteria: Urinary tract infection, menstruating (female), use of iron chelation medication. Healthy volunteers will be excluded in case of a known history of renal diseases or systemic iron overload.

Design outcomes

Primary

MeasureTime frame
The main study parameters are the level of urinary iron parameters (total iron, transferrin, NTBI and LPI relative to urinary creatinine concentration) in all study groups.

Secondary

MeasureTime frame
The secundary study parameters are the level of blood iron parameters (total iron, transferrin, NTBI, LPI and ferritin), (e)GFR, CRP, urinary albumin concentration relative to urinary creatinine concentration, a panel of specific proximal and distal tubular dysfunction/injury markers (KIM-1, L-FABP, GST-a for proximal and H-FABP, GST-pi, for distal tubules, respectively) relative to urinary creatinine concentration and urinary pH.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)